nodes	percent_of_prediction	percent_of_DWPC	metapath
Anastrozole—CYP19A1—Betamethasone—multiple sclerosis	0.233	0.34	CbGbCtD
Anastrozole—CYP19A1—Dexamethasone—multiple sclerosis	0.135	0.198	CbGbCtD
Anastrozole—CYP3A4—Fingolimod—multiple sclerosis	0.0703	0.103	CbGbCtD
Anastrozole—CYP3A4—Methylprednisolone—multiple sclerosis	0.0453	0.0663	CbGbCtD
Anastrozole—CYP3A4—Triamcinolone—multiple sclerosis	0.0343	0.0502	CbGbCtD
Anastrozole—CYP3A4—Mitoxantrone—multiple sclerosis	0.0331	0.0484	CbGbCtD
Anastrozole—CYP2C9—Dexamethasone—multiple sclerosis	0.0295	0.0431	CbGbCtD
Anastrozole—CYP3A4—Betamethasone—multiple sclerosis	0.0295	0.0431	CbGbCtD
Anastrozole—CYP3A4—Prednisolone—multiple sclerosis	0.0291	0.0425	CbGbCtD
Anastrozole—CYP3A4—Prednisone—multiple sclerosis	0.0275	0.0402	CbGbCtD
Anastrozole—CYP3A4—Dexamethasone—multiple sclerosis	0.0171	0.0251	CbGbCtD
Anastrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.000901	0.0514	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.000901	0.0514	CbGpPWpGaD
Anastrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000558	0.0319	CbGpPWpGaD
Anastrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000558	0.0319	CbGpPWpGaD
Anastrozole—CYP19A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000551	0.0315	CbGpPWpGaD
Anastrozole—CYP19A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000551	0.0315	CbGpPWpGaD
Anastrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000453	0.0258	CbGpPWpGaD
Anastrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000453	0.0258	CbGpPWpGaD
Anastrozole—CYP19A1—Ovarian Infertility Genes—PGR—multiple sclerosis	0.000432	0.0247	CbGpPWpGaD
Anastrozole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000389	0.0222	CbGpPWpGaD
Anastrozole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000389	0.0222	CbGpPWpGaD
Anastrozole—CYP19A1—FSH signaling pathway—BDNF—multiple sclerosis	0.000353	0.0201	CbGpPWpGaD
Anastrozole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000333	0.019	CbGpPWpGaD
Anastrozole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000333	0.019	CbGpPWpGaD
Anastrozole—CYP19A1—Ovarian Infertility Genes—VDR—multiple sclerosis	0.000302	0.0172	CbGpPWpGaD
Anastrozole—Erythema—Betamethasone—multiple sclerosis	0.000277	0.000927	CcSEcCtD
Anastrozole—Malaise—Triamcinolone—multiple sclerosis	0.000275	0.000921	CcSEcCtD
Anastrozole—Malaise—Methylprednisolone—multiple sclerosis	0.000275	0.000919	CcSEcCtD
Anastrozole—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000272	0.00091	CcSEcCtD
Anastrozole—Oedema—Prednisolone—multiple sclerosis	0.000271	0.000906	CcSEcCtD
Anastrozole—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000271	0.000906	CcSEcCtD
Anastrozole—CYP19A1—Endogenous sterols—POMC—multiple sclerosis	0.00027	0.0154	CbGpPWpGaD
Anastrozole—Dizziness—Azathioprine—multiple sclerosis	0.00027	0.000904	CcSEcCtD
Anastrozole—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00027	0.000903	CcSEcCtD
Anastrozole—Cough—Triamcinolone—multiple sclerosis	0.000267	0.000891	CcSEcCtD
Anastrozole—Hypertension—Triamcinolone—multiple sclerosis	0.000264	0.000882	CcSEcCtD
Anastrozole—Hypertension—Methylprednisolone—multiple sclerosis	0.000263	0.00088	CcSEcCtD
Anastrozole—Urticaria—Mitoxantrone—multiple sclerosis	0.000262	0.000878	CcSEcCtD
Anastrozole—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000262	0.000876	CcSEcCtD
Anastrozole—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000261	0.000873	CcSEcCtD
Anastrozole—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000261	0.000873	CcSEcCtD
Anastrozole—Myalgia—Triamcinolone—multiple sclerosis	0.00026	0.000869	CcSEcCtD
Anastrozole—Vomiting—Azathioprine—multiple sclerosis	0.00026	0.000869	CcSEcCtD
Anastrozole—Arthralgia—Methylprednisolone—multiple sclerosis	0.000259	0.000867	CcSEcCtD
Anastrozole—Myalgia—Methylprednisolone—multiple sclerosis	0.000259	0.000867	CcSEcCtD
Anastrozole—Anxiety—Methylprednisolone—multiple sclerosis	0.000259	0.000864	CcSEcCtD
Anastrozole—Rash—Azathioprine—multiple sclerosis	0.000258	0.000862	CcSEcCtD
Anastrozole—Dermatitis—Azathioprine—multiple sclerosis	0.000257	0.000861	CcSEcCtD
Anastrozole—Depression—Methotrexate—multiple sclerosis	0.000257	0.00086	CcSEcCtD
Anastrozole—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000257	0.00086	CcSEcCtD
Anastrozole—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000257	0.00086	CcSEcCtD
Anastrozole—Discomfort—Triamcinolone—multiple sclerosis	0.000257	0.000859	CcSEcCtD
Anastrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000257	0.0147	CbGpPWpGaD
Anastrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000257	0.0147	CbGpPWpGaD
Anastrozole—Discomfort—Methylprednisolone—multiple sclerosis	0.000256	0.000857	CcSEcCtD
Anastrozole—Headache—Azathioprine—multiple sclerosis	0.000256	0.000856	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000256	0.000856	CcSEcCtD
Anastrozole—Dry mouth—Triamcinolone—multiple sclerosis	0.000254	0.00085	CcSEcCtD
Anastrozole—Angioedema—Betamethasone—multiple sclerosis	0.000253	0.000847	CcSEcCtD
Anastrozole—Angioedema—Dexamethasone—multiple sclerosis	0.000253	0.000847	CcSEcCtD
Anastrozole—Confusional state—Methylprednisolone—multiple sclerosis	0.000251	0.000838	CcSEcCtD
Anastrozole—Malaise—Dexamethasone—multiple sclerosis	0.00025	0.000836	CcSEcCtD
Anastrozole—Malaise—Betamethasone—multiple sclerosis	0.00025	0.000836	CcSEcCtD
Anastrozole—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000249	0.000833	CcSEcCtD
Anastrozole—Oedema—Triamcinolone—multiple sclerosis	0.000249	0.000833	CcSEcCtD
Anastrozole—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000249	0.000832	CcSEcCtD
Anastrozole—Infection—Triamcinolone—multiple sclerosis	0.000248	0.000828	CcSEcCtD
Anastrozole—Sweating—Methotrexate—multiple sclerosis	0.000247	0.000827	CcSEcCtD
Anastrozole—Infection—Methylprednisolone—multiple sclerosis	0.000247	0.000826	CcSEcCtD
Anastrozole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000247	0.0141	CbGpPWpGaD
Anastrozole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000247	0.0141	CbGpPWpGaD
Anastrozole—Insomnia—Prednisolone—multiple sclerosis	0.000245	0.00082	CcSEcCtD
Anastrozole—Alopecia—Prednisone—multiple sclerosis	0.000245	0.000819	CcSEcCtD
Anastrozole—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000244	0.000816	CcSEcCtD
Anastrozole—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000244	0.0139	CbGpPWpGaD
Anastrozole—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000244	0.0139	CbGpPWpGaD
Anastrozole—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000243	0.000814	CcSEcCtD
Anastrozole—Paraesthesia—Prednisolone—multiple sclerosis	0.000243	0.000814	CcSEcCtD
Anastrozole—Nausea—Azathioprine—multiple sclerosis	0.000243	0.000812	CcSEcCtD
Anastrozole—Erythema—Prednisone—multiple sclerosis	0.000241	0.000807	CcSEcCtD
Anastrozole—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000241	0.000806	CcSEcCtD
Anastrozole—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00024	0.000804	CcSEcCtD
Anastrozole—CYP19A1—Biological oxidations—CYP24A1—multiple sclerosis	0.00024	0.0137	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—CYP27B1—multiple sclerosis	0.00024	0.0137	CbGpPWpGaD
Anastrozole—Hypertension—Dexamethasone—multiple sclerosis	0.000239	0.0008	CcSEcCtD
Anastrozole—Hypertension—Betamethasone—multiple sclerosis	0.000239	0.0008	CcSEcCtD
Anastrozole—CYP19A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000237	0.0135	CbGpPWpGaD
Anastrozole—CYP19A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000237	0.0135	CbGpPWpGaD
Anastrozole—Asthenia—Mitoxantrone—multiple sclerosis	0.000237	0.000793	CcSEcCtD
Anastrozole—Myalgia—Dexamethasone—multiple sclerosis	0.000236	0.000789	CcSEcCtD
Anastrozole—Myalgia—Betamethasone—multiple sclerosis	0.000236	0.000789	CcSEcCtD
Anastrozole—Anxiety—Betamethasone—multiple sclerosis	0.000235	0.000786	CcSEcCtD
Anastrozole—Anxiety—Dexamethasone—multiple sclerosis	0.000235	0.000786	CcSEcCtD
Anastrozole—Discomfort—Betamethasone—multiple sclerosis	0.000233	0.000779	CcSEcCtD
Anastrozole—Discomfort—Dexamethasone—multiple sclerosis	0.000233	0.000779	CcSEcCtD
Anastrozole—Haemoglobin—Methotrexate—multiple sclerosis	0.000233	0.000779	CcSEcCtD
Anastrozole—Pain—Prednisolone—multiple sclerosis	0.000232	0.000775	CcSEcCtD
Anastrozole—Haemorrhage—Methotrexate—multiple sclerosis	0.000232	0.000775	CcSEcCtD
Anastrozole—Hepatitis—Methotrexate—multiple sclerosis	0.000232	0.000775	CcSEcCtD
Anastrozole—Pharyngitis—Methotrexate—multiple sclerosis	0.00023	0.000769	CcSEcCtD
Anastrozole—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000227	0.013	CbGpPWpGaD
Anastrozole—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000227	0.000759	CcSEcCtD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.000227	0.013	CbGpPWpGaD
Anastrozole—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000227	0.000758	CcSEcCtD
Anastrozole—Oedema—Dexamethasone—multiple sclerosis	0.000226	0.000756	CcSEcCtD
Anastrozole—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000226	0.000756	CcSEcCtD
Anastrozole—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000226	0.000756	CcSEcCtD
Anastrozole—Oedema—Betamethasone—multiple sclerosis	0.000226	0.000756	CcSEcCtD
Anastrozole—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000226	0.000756	CcSEcCtD
Anastrozole—Insomnia—Triamcinolone—multiple sclerosis	0.000225	0.000754	CcSEcCtD
Anastrozole—Insomnia—Methylprednisolone—multiple sclerosis	0.000225	0.000752	CcSEcCtD
Anastrozole—Infection—Dexamethasone—multiple sclerosis	0.000225	0.000751	CcSEcCtD
Anastrozole—Infection—Betamethasone—multiple sclerosis	0.000225	0.000751	CcSEcCtD
Anastrozole—Ill-defined disorder—Prednisone—multiple sclerosis	0.000224	0.000749	CcSEcCtD
Anastrozole—Paraesthesia—Triamcinolone—multiple sclerosis	0.000224	0.000748	CcSEcCtD
Anastrozole—Feeling abnormal—Prednisolone—multiple sclerosis	0.000223	0.000747	CcSEcCtD
Anastrozole—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000223	0.000747	CcSEcCtD
Anastrozole—Anaemia—Prednisone—multiple sclerosis	0.000223	0.000746	CcSEcCtD
Anastrozole—Dyspnoea—Triamcinolone—multiple sclerosis	0.000222	0.000743	CcSEcCtD
Anastrozole—Angioedema—Prednisone—multiple sclerosis	0.000221	0.000737	CcSEcCtD
Anastrozole—Dyspepsia—Triamcinolone—multiple sclerosis	0.000219	0.000734	CcSEcCtD
Anastrozole—Erythema multiforme—Methotrexate—multiple sclerosis	0.000219	0.000732	CcSEcCtD
Anastrozole—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000219	0.000732	CcSEcCtD
Anastrozole—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000219	0.000731	CcSEcCtD
Anastrozole—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000219	0.000731	CcSEcCtD
Anastrozole—Malaise—Prednisone—multiple sclerosis	0.000218	0.000728	CcSEcCtD
Anastrozole—Anorexia—Betamethasone—multiple sclerosis	0.000216	0.000721	CcSEcCtD
Anastrozole—Anorexia—Dexamethasone—multiple sclerosis	0.000216	0.000721	CcSEcCtD
Anastrozole—Urticaria—Prednisolone—multiple sclerosis	0.000215	0.00072	CcSEcCtD
Anastrozole—Fatigue—Triamcinolone—multiple sclerosis	0.000215	0.000719	CcSEcCtD
Anastrozole—Fatigue—Methylprednisolone—multiple sclerosis	0.000214	0.000717	CcSEcCtD
Anastrozole—Pain—Triamcinolone—multiple sclerosis	0.000213	0.000713	CcSEcCtD
Anastrozole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000211	0.0121	CbGpPWpGaD
Anastrozole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000211	0.0121	CbGpPWpGaD
Anastrozole—Vomiting—Mitoxantrone—multiple sclerosis	0.00021	0.000702	CcSEcCtD
Anastrozole—Hypertension—Prednisone—multiple sclerosis	0.000208	0.000697	CcSEcCtD
Anastrozole—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000208	0.0119	CbGpPWpGaD
Anastrozole—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000208	0.0119	CbGpPWpGaD
Anastrozole—Rash—Mitoxantrone—multiple sclerosis	0.000208	0.000697	CcSEcCtD
Anastrozole—Dermatitis—Mitoxantrone—multiple sclerosis	0.000208	0.000696	CcSEcCtD
Anastrozole—Headache—Mitoxantrone—multiple sclerosis	0.000207	0.000692	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000206	0.000689	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000206	0.000689	CcSEcCtD
Anastrozole—Arthralgia—Prednisone—multiple sclerosis	0.000205	0.000687	CcSEcCtD
Anastrozole—Myalgia—Prednisone—multiple sclerosis	0.000205	0.000687	CcSEcCtD
Anastrozole—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000205	0.000687	CcSEcCtD
Anastrozole—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000205	0.000685	CcSEcCtD
Anastrozole—Anxiety—Prednisone—multiple sclerosis	0.000205	0.000685	CcSEcCtD
Anastrozole—Alopecia—Methotrexate—multiple sclerosis	0.000205	0.000685	CcSEcCtD
Anastrozole—Insomnia—Betamethasone—multiple sclerosis	0.000205	0.000684	CcSEcCtD
Anastrozole—Insomnia—Dexamethasone—multiple sclerosis	0.000205	0.000684	CcSEcCtD
Anastrozole—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000203	0.00068	CcSEcCtD
Anastrozole—Paraesthesia—Betamethasone—multiple sclerosis	0.000203	0.000679	CcSEcCtD
Anastrozole—Paraesthesia—Dexamethasone—multiple sclerosis	0.000203	0.000679	CcSEcCtD
Anastrozole—Discomfort—Prednisone—multiple sclerosis	0.000203	0.000679	CcSEcCtD
Anastrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.000203	0.0116	CbGpPWpGaD
Anastrozole—Erythema—Methotrexate—multiple sclerosis	0.000202	0.000674	CcSEcCtD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.0002	0.0114	CbGpPWpGaD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.0002	0.0114	CbGpPWpGaD
Anastrozole—Hypersensitivity—Prednisolone—multiple sclerosis	0.0002	0.000668	CcSEcCtD
Anastrozole—Dyspepsia—Betamethasone—multiple sclerosis	0.000199	0.000666	CcSEcCtD
Anastrozole—Dyspepsia—Dexamethasone—multiple sclerosis	0.000199	0.000666	CcSEcCtD
Anastrozole—Urticaria—Triamcinolone—multiple sclerosis	0.000198	0.000662	CcSEcCtD
Anastrozole—Urticaria—Methylprednisolone—multiple sclerosis	0.000198	0.000661	CcSEcCtD
Anastrozole—Dysgeusia—Methotrexate—multiple sclerosis	0.000198	0.00066	CcSEcCtD
Anastrozole—Body temperature increased—Triamcinolone—multiple sclerosis	0.000197	0.000659	CcSEcCtD
Anastrozole—Oedema—Prednisone—multiple sclerosis	0.000197	0.000659	CcSEcCtD
Anastrozole—Anaphylactic shock—Prednisone—multiple sclerosis	0.000197	0.000659	CcSEcCtD
Anastrozole—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000197	0.000657	CcSEcCtD
Anastrozole—Decreased appetite—Dexamethasone—multiple sclerosis	0.000197	0.000657	CcSEcCtD
Anastrozole—Decreased appetite—Betamethasone—multiple sclerosis	0.000197	0.000657	CcSEcCtD
Anastrozole—Nausea—Mitoxantrone—multiple sclerosis	0.000196	0.000656	CcSEcCtD
Anastrozole—Infection—Prednisone—multiple sclerosis	0.000196	0.000654	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000195	0.000653	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000195	0.000653	CcSEcCtD
Anastrozole—Back pain—Methotrexate—multiple sclerosis	0.000195	0.000652	CcSEcCtD
Anastrozole—Fatigue—Betamethasone—multiple sclerosis	0.000195	0.000652	CcSEcCtD
Anastrozole—Fatigue—Dexamethasone—multiple sclerosis	0.000195	0.000652	CcSEcCtD
Anastrozole—Pain—Dexamethasone—multiple sclerosis	0.000193	0.000647	CcSEcCtD
Anastrozole—Pain—Betamethasone—multiple sclerosis	0.000193	0.000647	CcSEcCtD
Anastrozole—Hyperhidrosis—Prednisone—multiple sclerosis	0.00019	0.000637	CcSEcCtD
Anastrozole—Anorexia—Prednisone—multiple sclerosis	0.000188	0.000628	CcSEcCtD
Anastrozole—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000187	0.000626	CcSEcCtD
Anastrozole—Anaemia—Methotrexate—multiple sclerosis	0.000186	0.000623	CcSEcCtD
Anastrozole—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000186	0.000623	CcSEcCtD
Anastrozole—Feeling abnormal—Betamethasone—multiple sclerosis	0.000186	0.000623	CcSEcCtD
Anastrozole—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000185	0.000618	CcSEcCtD
Anastrozole—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000185	0.000618	CcSEcCtD
Anastrozole—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000184	0.000614	CcSEcCtD
Anastrozole—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000183	0.000613	CcSEcCtD
Anastrozole—Malaise—Methotrexate—multiple sclerosis	0.000182	0.000608	CcSEcCtD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000181	0.0103	CbGpPWpGaD
Anastrozole—Leukopenia—Methotrexate—multiple sclerosis	0.000181	0.000604	CcSEcCtD
Anastrozole—Urticaria—Dexamethasone—multiple sclerosis	0.00018	0.000601	CcSEcCtD
Anastrozole—Urticaria—Betamethasone—multiple sclerosis	0.00018	0.000601	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000179	0.0006	CcSEcCtD
Anastrozole—Dizziness—Prednisolone—multiple sclerosis	0.000179	0.000599	CcSEcCtD
Anastrozole—Asthenia—Triamcinolone—multiple sclerosis	0.000179	0.000598	CcSEcCtD
Anastrozole—Abdominal pain—Betamethasone—multiple sclerosis	0.000179	0.000598	CcSEcCtD
Anastrozole—Body temperature increased—Betamethasone—multiple sclerosis	0.000179	0.000598	CcSEcCtD
Anastrozole—Body temperature increased—Dexamethasone—multiple sclerosis	0.000179	0.000598	CcSEcCtD
Anastrozole—Abdominal pain—Dexamethasone—multiple sclerosis	0.000179	0.000598	CcSEcCtD
Anastrozole—Asthenia—Methylprednisolone—multiple sclerosis	0.000178	0.000597	CcSEcCtD
Anastrozole—Insomnia—Prednisone—multiple sclerosis	0.000178	0.000596	CcSEcCtD
Anastrozole—Paraesthesia—Prednisone—multiple sclerosis	0.000177	0.000591	CcSEcCtD
Anastrozole—Pruritus—Triamcinolone—multiple sclerosis	0.000176	0.00059	CcSEcCtD
Anastrozole—Cough—Methotrexate—multiple sclerosis	0.000176	0.000588	CcSEcCtD
Anastrozole—Pruritus—Methylprednisolone—multiple sclerosis	0.000176	0.000588	CcSEcCtD
Anastrozole—Dyspepsia—Prednisone—multiple sclerosis	0.000173	0.00058	CcSEcCtD
Anastrozole—Arthralgia—Methotrexate—multiple sclerosis	0.000172	0.000574	CcSEcCtD
Anastrozole—Chest pain—Methotrexate—multiple sclerosis	0.000172	0.000574	CcSEcCtD
Anastrozole—Myalgia—Methotrexate—multiple sclerosis	0.000172	0.000574	CcSEcCtD
Anastrozole—Decreased appetite—Prednisone—multiple sclerosis	0.000171	0.000572	CcSEcCtD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000171	0.00977	CbGpPWpGaD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000171	0.00977	CbGpPWpGaD
Anastrozole—Rash—Prednisolone—multiple sclerosis	0.000171	0.000571	CcSEcCtD
Anastrozole—Dermatitis—Prednisolone—multiple sclerosis	0.000171	0.000571	CcSEcCtD
Anastrozole—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00017	0.000569	CcSEcCtD
Anastrozole—Fatigue—Prednisone—multiple sclerosis	0.00017	0.000568	CcSEcCtD
Anastrozole—Headache—Prednisolone—multiple sclerosis	0.00017	0.000568	CcSEcCtD
Anastrozole—Discomfort—Methotrexate—multiple sclerosis	0.00017	0.000567	CcSEcCtD
Anastrozole—Constipation—Prednisone—multiple sclerosis	0.000168	0.000563	CcSEcCtD
Anastrozole—Confusional state—Methotrexate—multiple sclerosis	0.000166	0.000555	CcSEcCtD
Anastrozole—Dizziness—Triamcinolone—multiple sclerosis	0.000165	0.000551	CcSEcCtD
Anastrozole—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000165	0.00055	CcSEcCtD
Anastrozole—Dizziness—Methylprednisolone—multiple sclerosis	0.000164	0.00055	CcSEcCtD
Anastrozole—Infection—Methotrexate—multiple sclerosis	0.000164	0.000547	CcSEcCtD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000163	0.0093	CbGpPWpGaD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000163	0.0093	CbGpPWpGaD
Anastrozole—Feeling abnormal—Prednisone—multiple sclerosis	0.000162	0.000543	CcSEcCtD
Anastrozole—Asthenia—Dexamethasone—multiple sclerosis	0.000162	0.000543	CcSEcCtD
Anastrozole—Asthenia—Betamethasone—multiple sclerosis	0.000162	0.000543	CcSEcCtD
Anastrozole—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000161	0.000539	CcSEcCtD
Anastrozole—Nausea—Prednisolone—multiple sclerosis	0.000161	0.000538	CcSEcCtD
Anastrozole—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000161	0.00918	CbGpPWpGaD
Anastrozole—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000161	0.00918	CbGpPWpGaD
Anastrozole—Pruritus—Betamethasone—multiple sclerosis	0.00016	0.000535	CcSEcCtD
Anastrozole—Pruritus—Dexamethasone—multiple sclerosis	0.00016	0.000535	CcSEcCtD
Anastrozole—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000159	0.000532	CcSEcCtD
Anastrozole—Vomiting—Triamcinolone—multiple sclerosis	0.000158	0.00053	CcSEcCtD
Anastrozole—Vomiting—Methylprednisolone—multiple sclerosis	0.000158	0.000529	CcSEcCtD
Anastrozole—Rash—Triamcinolone—multiple sclerosis	0.000157	0.000526	CcSEcCtD
Anastrozole—Dermatitis—Triamcinolone—multiple sclerosis	0.000157	0.000525	CcSEcCtD
Anastrozole—Anorexia—Methotrexate—multiple sclerosis	0.000157	0.000525	CcSEcCtD
Anastrozole—Rash—Methylprednisolone—multiple sclerosis	0.000157	0.000524	CcSEcCtD
Anastrozole—Dermatitis—Methylprednisolone—multiple sclerosis	0.000157	0.000524	CcSEcCtD
Anastrozole—Urticaria—Prednisone—multiple sclerosis	0.000156	0.000523	CcSEcCtD
Anastrozole—Headache—Triamcinolone—multiple sclerosis	0.000156	0.000522	CcSEcCtD
Anastrozole—Headache—Methylprednisolone—multiple sclerosis	0.000156	0.000521	CcSEcCtD
Anastrozole—Body temperature increased—Prednisone—multiple sclerosis	0.000156	0.000521	CcSEcCtD
Anastrozole—Abdominal pain—Prednisone—multiple sclerosis	0.000156	0.000521	CcSEcCtD
Anastrozole—Diarrhoea—Dexamethasone—multiple sclerosis	0.000155	0.000517	CcSEcCtD
Anastrozole—Diarrhoea—Betamethasone—multiple sclerosis	0.000155	0.000517	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00015	0.000501	CcSEcCtD
Anastrozole—Dizziness—Dexamethasone—multiple sclerosis	0.00015	0.0005	CcSEcCtD
Anastrozole—Dizziness—Betamethasone—multiple sclerosis	0.00015	0.0005	CcSEcCtD
Anastrozole—Insomnia—Methotrexate—multiple sclerosis	0.000149	0.000498	CcSEcCtD
Anastrozole—Nausea—Triamcinolone—multiple sclerosis	0.000148	0.000495	CcSEcCtD
Anastrozole—Paraesthesia—Methotrexate—multiple sclerosis	0.000148	0.000494	CcSEcCtD
Anastrozole—Nausea—Methylprednisolone—multiple sclerosis	0.000148	0.000494	CcSEcCtD
Anastrozole—Dyspnoea—Methotrexate—multiple sclerosis	0.000147	0.000491	CcSEcCtD
Anastrozole—Somnolence—Methotrexate—multiple sclerosis	0.000146	0.000489	CcSEcCtD
Anastrozole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000146	0.00835	CbGpPWpGaD
Anastrozole—Hypersensitivity—Prednisone—multiple sclerosis	0.000145	0.000485	CcSEcCtD
Anastrozole—Dyspepsia—Methotrexate—multiple sclerosis	0.000145	0.000484	CcSEcCtD
Anastrozole—Vomiting—Dexamethasone—multiple sclerosis	0.000144	0.000481	CcSEcCtD
Anastrozole—Vomiting—Betamethasone—multiple sclerosis	0.000144	0.000481	CcSEcCtD
Anastrozole—Decreased appetite—Methotrexate—multiple sclerosis	0.000143	0.000478	CcSEcCtD
Anastrozole—Rash—Betamethasone—multiple sclerosis	0.000143	0.000477	CcSEcCtD
Anastrozole—Rash—Dexamethasone—multiple sclerosis	0.000143	0.000477	CcSEcCtD
Anastrozole—Dermatitis—Dexamethasone—multiple sclerosis	0.000142	0.000476	CcSEcCtD
Anastrozole—Dermatitis—Betamethasone—multiple sclerosis	0.000142	0.000476	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000142	0.000475	CcSEcCtD
Anastrozole—Fatigue—Methotrexate—multiple sclerosis	0.000142	0.000475	CcSEcCtD
Anastrozole—Headache—Dexamethasone—multiple sclerosis	0.000142	0.000474	CcSEcCtD
Anastrozole—Headache—Betamethasone—multiple sclerosis	0.000142	0.000474	CcSEcCtD
Anastrozole—Asthenia—Prednisone—multiple sclerosis	0.000141	0.000473	CcSEcCtD
Anastrozole—Pain—Methotrexate—multiple sclerosis	0.000141	0.000471	CcSEcCtD
Anastrozole—Pruritus—Prednisone—multiple sclerosis	0.000139	0.000466	CcSEcCtD
Anastrozole—Feeling abnormal—Methotrexate—multiple sclerosis	0.000136	0.000454	CcSEcCtD
Anastrozole—Diarrhoea—Prednisone—multiple sclerosis	0.000135	0.000451	CcSEcCtD
Anastrozole—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000135	0.00045	CcSEcCtD
Anastrozole—CYP19A1—FSH signaling pathway—MAPK1—multiple sclerosis	0.000135	0.00768	CbGpPWpGaD
Anastrozole—Nausea—Betamethasone—multiple sclerosis	0.000134	0.000449	CcSEcCtD
Anastrozole—Nausea—Dexamethasone—multiple sclerosis	0.000134	0.000449	CcSEcCtD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000132	0.00754	CbGpPWpGaD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000132	0.00754	CbGpPWpGaD
Anastrozole—Urticaria—Methotrexate—multiple sclerosis	0.000131	0.000437	CcSEcCtD
Anastrozole—Dizziness—Prednisone—multiple sclerosis	0.00013	0.000436	CcSEcCtD
Anastrozole—Abdominal pain—Methotrexate—multiple sclerosis	0.00013	0.000435	CcSEcCtD
Anastrozole—Body temperature increased—Methotrexate—multiple sclerosis	0.00013	0.000435	CcSEcCtD
Anastrozole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000127	0.00727	CbGpPWpGaD
Anastrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000126	0.00717	CbGpPWpGaD
Anastrozole—Vomiting—Prednisone—multiple sclerosis	0.000125	0.000419	CcSEcCtD
Anastrozole—Rash—Prednisone—multiple sclerosis	0.000124	0.000415	CcSEcCtD
Anastrozole—Dermatitis—Prednisone—multiple sclerosis	0.000124	0.000415	CcSEcCtD
Anastrozole—Headache—Prednisone—multiple sclerosis	0.000123	0.000413	CcSEcCtD
Anastrozole—Hypersensitivity—Methotrexate—multiple sclerosis	0.000121	0.000406	CcSEcCtD
Anastrozole—Asthenia—Methotrexate—multiple sclerosis	0.000118	0.000395	CcSEcCtD
Anastrozole—Nausea—Prednisone—multiple sclerosis	0.000117	0.000391	CcSEcCtD
Anastrozole—Pruritus—Methotrexate—multiple sclerosis	0.000116	0.000389	CcSEcCtD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000114	0.00649	CbGpPWpGaD
Anastrozole—Diarrhoea—Methotrexate—multiple sclerosis	0.000113	0.000377	CcSEcCtD
Anastrozole—Dizziness—Methotrexate—multiple sclerosis	0.000109	0.000364	CcSEcCtD
Anastrozole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000109	0.00621	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000106	0.00607	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000106	0.00607	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000105	0.00599	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000105	0.00599	CbGpPWpGaD
Anastrozole—Vomiting—Methotrexate—multiple sclerosis	0.000105	0.00035	CcSEcCtD
Anastrozole—Rash—Methotrexate—multiple sclerosis	0.000104	0.000347	CcSEcCtD
Anastrozole—Dermatitis—Methotrexate—multiple sclerosis	0.000104	0.000347	CcSEcCtD
Anastrozole—Headache—Methotrexate—multiple sclerosis	0.000103	0.000345	CcSEcCtD
Anastrozole—CYP19A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000102	0.00581	CbGpPWpGaD
Anastrozole—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.0001	0.00573	CbGpPWpGaD
Anastrozole—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	9.89e-05	0.00565	CbGpPWpGaD
Anastrozole—Nausea—Methotrexate—multiple sclerosis	9.78e-05	0.000327	CcSEcCtD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.23e-05	0.00527	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.23e-05	0.00527	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	9.09e-05	0.00519	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	9.09e-05	0.00519	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.97e-05	0.00512	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.97e-05	0.00512	CbGpPWpGaD
Anastrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	8.4e-05	0.00479	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	7.02e-05	0.00401	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	7.02e-05	0.00401	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.92e-05	0.00395	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.92e-05	0.00395	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—SRM—multiple sclerosis	5.84e-05	0.00333	CbGpPWpGaD
Anastrozole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.56e-05	0.00317	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—POMC—multiple sclerosis	5.41e-05	0.00309	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	4.89e-05	0.00279	CbGpPWpGaD
Anastrozole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.75e-05	0.00271	CbGpPWpGaD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.5e-05	0.00257	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	4.36e-05	0.00249	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	4.34e-05	0.00248	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	4.11e-05	0.00235	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	4.11e-05	0.00235	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.08e-05	0.00233	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.08e-05	0.00233	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.02e-05	0.00229	CbGpPWpGaD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.85e-05	0.0022	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GPC5—multiple sclerosis	3.76e-05	0.00215	CbGpPWpGaD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.66e-05	0.00209	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.49e-05	0.00199	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.49e-05	0.00199	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	3.47e-05	0.00198	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	3.4e-05	0.00194	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	3.39e-05	0.00194	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	3.39e-05	0.00193	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	3.32e-05	0.0019	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	3.16e-05	0.00181	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3.16e-05	0.00181	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—RRM1—multiple sclerosis	3.12e-05	0.00178	CbGpPWpGaD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.97e-05	0.0017	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—SRM—multiple sclerosis	2.58e-05	0.00147	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.42e-05	0.00138	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.39e-05	0.00137	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SRM—multiple sclerosis	2.21e-05	0.00126	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.08e-05	0.00119	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.04e-05	0.00117	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.89e-05	0.00108	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.82e-05	0.00104	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.82e-05	0.00104	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—BCHE—multiple sclerosis	1.79e-05	0.00102	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.78e-05	0.00102	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SRM—multiple sclerosis	1.7e-05	0.000972	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.66e-05	0.00095	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.58e-05	0.000901	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.55e-05	0.000888	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.55e-05	0.000888	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.52e-05	0.000868	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.42e-05	0.000812	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.38e-05	0.000787	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.2e-05	0.000685	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.2e-05	0.000685	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.18e-05	0.000673	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.1e-05	0.000627	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—APOE—multiple sclerosis	1.08e-05	0.000615	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.07e-05	0.000611	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—POMC—multiple sclerosis	9.25e-06	0.000528	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.19e-06	0.000525	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.14e-06	0.000522	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—RRM1—multiple sclerosis	9.09e-06	0.000519	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ALB—multiple sclerosis	8.43e-06	0.000481	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.38e-06	0.000478	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—BCHE—multiple sclerosis	7.92e-06	0.000452	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.85e-06	0.000448	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.16e-06	0.000409	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—BCHE—multiple sclerosis	6.77e-06	0.000386	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.22e-06	0.000298	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—APOE—multiple sclerosis	4.76e-06	0.000272	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—POMC—multiple sclerosis	4.09e-06	0.000234	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—APOE—multiple sclerosis	4.07e-06	0.000232	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ALB—multiple sclerosis	3.73e-06	0.000213	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—POMC—multiple sclerosis	3.5e-06	0.0002	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ALB—multiple sclerosis	3.19e-06	0.000182	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—APOE—multiple sclerosis	3.14e-06	0.000179	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—POMC—multiple sclerosis	2.7e-06	0.000154	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ALB—multiple sclerosis	2.46e-06	0.000141	CbGpPWpGaD
